SSRIs联合作业疗法对卒中后抑郁患者神经递质、心理水平及日常生活能力改善情况的影响
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

黑龙江省卫生健康委科研项目(20222020011107); 黑龙江省中医药科研项目(ZHY2023-104);


Effect of combining SSRIs with occupational therapy on neurotransmitter levels,psychological well-being,and activities of daily living in individuals diagnosed with post-stroke depression
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的:探究选择性血清素再摄取抑制剂(SSRIs)联合作业疗法(OT)对卒中后抑郁(PSD)患者神经递质、心理水平及日常生活能力改善情况。方法:纳入90例PSD患者作为研究对象,按照治疗方式不同分为对照组(n=45)和试验组(n=45)。对照组采用SSRIs治疗;试验组采用SSRIs结合OT治疗。比较两组患者治疗后总有效率、去甲肾上腺素(NE)、5-羟色胺(5-HT)、脑源性神经营养因子(BDNF)、胰岛素样生长因子-1(IGF-1)水平、汉密尔顿抑郁量表(HAMD)评分、日常生活活动(ADL)评分、匹兹堡睡眠质量指数量表(PSQI)评分及不良反应发生情况。结果:两组患者治疗总有效率试验组95.56%高于对照组的80.00%(P<0.05);治疗后,两组患者血清NE、IGF-1、5-HT、BDNF水平均改善(P<0.05),且试验组改善优于对照组(P<0.05);两组患者ADL评分均升高(P<0.05),PSQI评分均降低(P<0.05),且试验组患者ADL、PSQI评分均较对照组改善更佳(P<0.05);试验组患者不良反应总发生率为2.22%,低于对照组的17.78%(P<0.05)。结论:PSD患者使用SSRIs联合OT治疗,能改善心理水平、睡眠质量,调控神经递质,进而提高日常生活能力,增加治疗安全性,优势显著。

    Abstract:

    Objective:To investigate the impact of combining selective serotonin reuptake inhibitors(SSRIs)with occupational therapy(OT)on neurological functioning,psychological well-being,and activities of daily living in individuals diagnosed with post-stroke depression(PSD).Methods:A total of 90 patients diagnosed with post-stroke depression were selected as the research subjects.They were divided into two groups according to different treatment methods,namely the control group(n=45)and the experimental group(n=45).The control group received treatment with SSRIs,while the experimental group received a combination of SSRIs and OT.The overall treatment efficacy,levels of norepinephrine(NE),5-hydroxytryptamine(5-HT),brain-derived neurotrophic factor(BDNF),insulin-like growth factor-1(IGF-1),Hamilton depression scale(HAMD)score,activities of daily living(ADL)score,and Pittsburgh sleep quality Index(PSQ)were compared between the two groups before and after treatment,including the incidence of ad-verse reactions.Results:The total effective rates of the the experimental group was higher than that of the control group(95.56%vs.80.00%,P<0.05).After treatment,the serum levels of NE,IGF-1,5-HT,and BDNF in both groups exhibited improvement compared to pre-treatment levels(P<0.05).Furthermore,the experimental group demonstrated superior post-treatment serum levels of NE,IGF-1,5-HT,and BDNF when compared to the control group(P<0.05).After treatment,the ADL scores of both groups exhibited a signifi-cant improvement compared to pre-treatment levels(P<0.05),the PSQI scores of both groups demonstrated a decrease in comparison to pre-treatment values(P<0.05).Moreover,the experimental group displayed superior post-treatment ADL and PSQI scores when compared to the control group(P<0.05).The incidence of adverse reactions in the two groups was 2.22%and 17.78%,respective-ly,with a lower rate observed in the experimental group compared to the control group(P<0.05).Conclusion:The use of SSRIs com-bined with OT treatment in PSD patients can enhance psychological well-being,improve sleep quality,regulate neurotransmitter levels,thereby enhancing daily functioning and increasing the safety profile of the treatment.This approach offers significant advantages.

    参考文献
    相似文献
    引证文献
引用本文

王皇予;冯琳;陆丽娜;班维固;滕秀英;. SSRIs联合作业疗法对卒中后抑郁患者神经递质、心理水平及日常生活能力改善情况的影响[J].川北医学院学报,2025,40(3):310-313 318.

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-07-24
  • 出版日期:
文章二维码